| Dr Anthony Oduje Isedeh Jr, MD | |
|
20 York Street, Cb-2041, New Haven, CT 06514-3220 | |
| (203) 688-4748 | |
| (203) 688-4740 |
| Full Name | Dr Anthony Oduje Isedeh Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 20 York Street, Cb-2041, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639445539 | NPI | - | NPPES |
| 1639445539 | Medicaid | VA | |
| 1639445539 | Other | VA | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 25MA09458100 (New Jersey) | Secondary |
| 208M00000X | Hospitalist | 62045 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newark Beth Israel Medical Center | Newark, NJ | Hospital |
| St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
| Newton Medical Center | Newton, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rwjbh Emergency Medicine Associates, Llc | 0941612840 | 613 |
| Practice Associates Medical Group | 5890703177 | 1116 |
| Passaic Hospitalist Services, Llc | 8426404484 | 28 |
| St Josephs Medical Group Pc | 8628470325 | 200 |
| Post Acute Specialists Llc | 1951676568 | 70 |
| Post Acute Specialists Llc | 1951676568 | 70 |
| Post Acute Specialists Llc | 1951676568 | 70 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | Nbimc Department Of Internal |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114985702 PECOS PAC ID: 7113814401 Enrollment ID: O20040302000344 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | St Josephs Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497791297 PECOS PAC ID: 9739171984 Enrollment ID: O20040330001612 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | Barnabas Health Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | Mission Hospitalists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629325196 PECOS PAC ID: 4183873359 Enrollment ID: O20121003000260 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | Pai Participant 25 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568028314 PECOS PAC ID: 3072842442 Enrollment ID: O20190910002368 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | Post Acute Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114441565 PECOS PAC ID: 1951676568 Enrollment ID: O20200511000168 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | Rwjbh Emergency Medicine Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912510041 PECOS PAC ID: 0941612840 Enrollment ID: O20201217002547 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | St Josephs Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205425519 PECOS PAC ID: 8628470325 Enrollment ID: O20210716000520 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Entity Name | Passaic Hospitalist Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144903733 PECOS PAC ID: 8426404484 Enrollment ID: O20231026002969 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony Oduje Isedeh Jr, MD 201 Lyons Ave, Newark, NJ 07011 Ph: (973) 926-7000 | Dr Anthony Oduje Isedeh Jr, MD 20 York Street, Cb-2041, New Haven, CT 06514-3220 Ph: (203) 688-4748 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.
With the prodding of new federal legislation, electronic health records (EHRs) are rapidly becoming part of the daily practice of hospital nurses - the frontline providers of care. In the first large study of its kind, researchers at the University of Pennsylvania School of Nursing determined that nurses working with EHRs consistently reported more improvements to nursing care and better health outcomes for patients than nurses working in hospitals without this technology.
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
Rheonix, Inc., developer of the Rheonix CARD system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method" to the Company.
› Verified 3 days ago
Alexander B Pine, MD, PHD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 20 York St, Cb-2041, New Haven, CT 06510 Phone: 203-688-4748 Fax: 203-688-4740 | |
Alina Rakhuba, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 20 York Street, Cb-2041, New Haven, CT 06510 Phone: 203-688-4748 Fax: 203-688-4740 | |
Omar Yasser Abed Shakhtour, MBBS Hospitalist Medicare: Medicare Enrolled Practice Location: 20 York Street, Cb-2041, New Haven, CT 06510 Phone: 036-884-7482 Fax: 036-884-7402 | |
Dr. Deepti Canchi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4748 Fax: 203-688-4740 | |
Christina Nefeli Dimopoulos, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Dr. Nidhi Shah, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 20 York Street, Cb-2041, New Haven, CT 06510 Phone: 203-688-4748 Fax: 203-688-4740 | |
Dr. Rupert Dogbey, MBCHB Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1450 Chapel St, New Haven, CT 06511 Phone: 203-789-3034 |